Time to Positive Blood Cultures Among Critically Ill Children Admitted to the PICU.


Journal

Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347

Informations de publication

Date de publication:
01 Jul 2024
Historique:
medline: 5 7 2024
pubmed: 5 7 2024
entrez: 5 7 2024
Statut: epublish

Résumé

Our study aimed to assess the time to positivity (TTP) of clinically significant blood cultures in critically ill children admitted to the PICU. Retrospective review of positive blood cultures in patients admitted or transferred to the PICU. Large tertiary-care medical center with over 90 PICU beds. Patients 0-20 years old with bacteremia admitted or transferred to the PICU. None. The primary endpoint was the TTP, defined as time from blood culture draw to initial Gram stain result. Secondary endpoints included percentage of cultures reported by elapsed time, as well as the impact of pathogen and host immune status on TTP. Host immune status was classified as previously healthy, standard risk, or immunocompromised. Linear regression for TTP was performed to account for age, blood volume, and Gram stain. Among 164 episodes of clinically significant bacteremia, the median TTP was 13.3 hours (interquartile range, 10.7-16.8 hr). Enterobacterales, Staphylococcus aureus, Streptococcus agalactiae, and Streptococcus pneumoniae were most commonly identified. By 12, 24, 36, and 48 hours, 37%, 89%, 95%, and 97% of positive cultures had resulted positive, respectively. Median TTP stratified by host immune status was 13.2 hours for previously healthy patients, 14.0 hours for those considered standard risk, and 10.6 hours for immunocompromised patients (p = 0.001). Median TTP was found to be independent of blood volume. No difference was seen in TTP for Gram-negative vs. Gram-positive organisms (12.2 vs. 13.9 hr; p = 0.2). Among critically ill children, 95% of clinically significant blood cultures had an initial positive result within 36 hours, regardless of host immune status. Need for antimicrobial therapy should be frequently reassessed and implementation of a shorter duration of empiric antibiotics should be considered in patients with low suspicion for infection.

Identifiants

pubmed: 38968174
doi: 10.1097/CCE.0000000000001115
pii: 02107256-202407000-00016
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1115

Informations de copyright

Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.

Déclaration de conflit d'intérêts

The authors have disclosed that they do not have any potential conflicts of interest.

Références

Liu VX, Fielding-Singh V, Greene JD, et al.: The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 2017; 196:856–863
Centers for Disease Control and Prevention: Antibiotic Resistance Threats in the United States. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2019
Dierig A, Berger C, Agyeman PKA, et al.; Swiss Pediatric Sepsis Study: Time-to-positivity of blood cultures in children with sepsis. Front Pediatr 2018; 6:222
Biondi EA, Mischler M, Jerardi KE, et al.; Pediatric Research in Inpatient Settings (PRIS) Network: Blood culture time to positivity in febrile infants with bacteremia. JAMA Pediatr 2014; 168:844–849
Pan F, Zhao W, Zhang H: Value of time to positivity of blood culture in children with bloodstream infections. Can J Infect Dis Med Microbiol 2019; 2019:5975837
Peralta G, Roiz MP, Sanchez MB, et al.: Time-to-positivity in patients with Escherichia coli bacteraemia. Clin Microbiol Infect 2007; 13:1077–1082
Arias-Felipe A, Ramirez-Berrios J, Recio-Martinez R, et al.: Determining time to positivity of blood cultures in a neonatal unit. J Pediatr Infect Dis Soc 2022; 11:510–513
Kuzniewicz MW, Mukhopadhyay S, Li S, et al.: Time to positivity of neonatal blood cultures for early-onset sepsis. Pediatr Infect Dis J 2020; 39:634–640
Lefebvre CE, Renaud C, Chartrand C: Time to positivity of blood cultures in infants 0 to 90 days old presenting to the emergency department: Is 36 hours enough? J Pediatr Infect Dis Soc 2017; 6:28–32
Ludwig Sanz-Orrio G, Noguera-Julian A, Rives Solá S, et al.: Blood culture time to positivity in oncology pediatric patients. Enferm Infecc Microbiol Clin (Engl Ed) 2018; 36:320–321
R Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2018
Wickham H, François R, Henry L, et al.: dplyr: A Grammar of Data Manipulation. Version 0.7.6 Edition. p R package, 2018
Therneau T: A Package for Survival Analysis in R. Version 3.2-11 Edition. p R Package, 2021
Dien Bard J, McElvania TeKippe E: Diagnosis of bloodstream infections in children. J Clin Microbiol 2016; 54:1418–1424
Isaacman DJ, Karasic RB, Reynolds EA, et al.: Effect of number of blood cultures and volume of blood on detection of bacteremia in children. J Pediatr 1996; 128:190–195
Connell TG, Rele M, Cowley D, et al.: How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children’s hospital. Pediatrics 2007; 119:891–896
Arpi M, Bentzon MW, Jensen J, et al.: Importance of blood volume cultured in the detection of bacteremia. Eur J Clin Microbiol Infect Dis 1989; 8:838–842
Plorde JJ, Tenover FC, Carlson LG: Specimen volume versus yield in the BACTEC blood culture system. J Clin Microbiol 1985; 22:292–295
Astorga MC, Piscitello KJ, Menda N, et al.: Antibiotic stewardship in the neonatal intensive care unit: Effects of an automatic 48-hour antibiotic stop order on antibiotic use. J Pediatr Infect Dis Soc 2019; 8:310–316
Karandikar MV, Milliren CE, Zaboulian R, et al.: Limiting vancomycin exposure in pediatric oncology patients with febrile neutropenia may be associated with decreased vancomycin-resistant enterococcus incidence. J Pediatr Infect Dis Soc 2020; 9:428–436

Auteurs

Stephanie M Yasechko (SM)

Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Margot M Hillyer (MM)

Department of Pediatrics, Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA.

Alison G C Smith (AGC)

Department of Internal Medicine, Duke University School of Medicine, Durham, NC.

Anna L Rodenbough (AL)

Department of Pediatrics, Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA.

Alfred J Fernandez (AJ)

Department of Pharmacy, Children's Healthcare of Atlanta, Atlanta, GA.

Mark D Gonzalez (MD)

Division of Pathology, Children's Healthcare of Atlanta, Atlanta, GA.

Preeti Jaggi (P)

Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH